Kevin Fournier, IBM
An IBM counsel has discussed how companies can harness their IP and gave an overview of the impact of artificial intelligence on healthcare.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
LSPN Europe 2017, IBM, mergers & acquisitions, investments, artificial intelligence, patent, patentee, Kevin Fournier, technology, Watson, life sciences